CN113149895A - 一种合成异喹啉酮类化合物或吡啶酮类化合物的方法 - Google Patents

一种合成异喹啉酮类化合物或吡啶酮类化合物的方法 Download PDF

Info

Publication number
CN113149895A
CN113149895A CN202110267724.2A CN202110267724A CN113149895A CN 113149895 A CN113149895 A CN 113149895A CN 202110267724 A CN202110267724 A CN 202110267724A CN 113149895 A CN113149895 A CN 113149895A
Authority
CN
China
Prior art keywords
compounds
compound
synthesizing
pyridone
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110267724.2A
Other languages
English (en)
Other versions
CN113149895B (zh
Inventor
孙嫚嫚
杨健国
吴海建
张晶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taizhou University
Original Assignee
Taizhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taizhou University filed Critical Taizhou University
Priority to CN202110267724.2A priority Critical patent/CN113149895B/zh
Publication of CN113149895A publication Critical patent/CN113149895A/zh
Application granted granted Critical
Publication of CN113149895B publication Critical patent/CN113149895B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/584—Recycling of catalysts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了一种合成异喹啉酮类化合物或吡啶酮类化合物的方法，包括：在钯催化剂和助催化剂的作用下，苯甲酰胺类化合物或丙烯酰胺类化合物与苯丙烯类化合物在有机溶剂中进行反应，反应结束后经过后处理得到所述的异喹啉酮类化合物或吡啶酮类化合物。该方法原料简单易得、条件温和、转化高效、区域选择性高、原子利用率高且操作简单。

Description

一种合成异喹啉酮类化合物或吡啶酮类化合物的方法
技术领域
本发明属于有机合成领域，具体涉及一种合成异喹啉酮类化合物或吡啶酮类化合物的方法。
背景技术
异喹啉酮和吡啶酮是两种活性天然产物和药物分子中重要的结构骨架。合成这两类化合物的传统方法包括6π-电环化反应、Larock-型杂环化反应、分子内胺羰环化反应、邻卤代苯甲酰胺与炔烃的环加成反应等，存在底物复杂和原子利用率低的缺点。过渡金属催化的导向C-H活化环加成反应是从简单易得的底物经串联反应模式合成复杂环状化合物的重要方法。目前以苯甲酰胺和炔烃或联烯化合物已经实现了异喹啉酮化合物的合成，而以苯甲酰胺或丙烯酰胺和烯烃为原料，经一锅多步反应合成异喹啉酮或吡啶酮的方法还没有报道。烯烃结构广泛存在于天然产物中，烯烃化合物便宜、易得，因此发展以烯烃为底物，与苯甲酰胺或丙烯酰胺合成异喹啉酮或吡啶酮的方法具有重要意义。
烯烃化合物性质活泼、反应位点多，因此在过渡金属催化的导向C-H活化与烯烃的反应中存在区域选择性问题。如何高区域选择性地获得单一产物是化学研究中非常重要的课题。经化学家们研究发现，导向基团可以起到关键作用。例如，以CONHOPiv或CONHCl为导向基可在金属铑或钴催化下实现苯甲酰胺与苯丙烯的[4+2]环加成反应合成二氢异喹啉酮化合物，以NH-pyrimidin为导向基可在金属铑催化下实现苯胺与苯丙烯的[3+2]环加成脱氢反应合成吲哚化合物。
发明内容
本发明提供了一种合成异喹啉酮类化合物或吡啶酮类化合物的方法，该方法，该方法原料简单易得、条件温和、转化高效、区域选择性高、原子利用率高且操作简单。
一种合成异喹啉酮类化合物或吡啶酮类化合物的方法，包括：在钯催化剂和助催化剂的作用下，苯甲酰胺类化合物(1)或丙烯酰胺类化合物(4)与苯丙烯类化合物(2)在有机溶剂中进行反应，反应结束后经过后处理得到所述的异喹啉酮类化合物(3)或吡啶酮类化合物(5)；
反应式如下：
Figure BDA0002972613120000021
上式中，R为苯基或者烷基取代的磺酰基；
R1为H、C1～C4烷基、C1～C4烷氧基、三氟甲基或卤素中的一个或者多个；
R2为H、C1～C4烷基、苯基或卤素；
R3和R4为苯基、C1～C4烷基，或者R3、R4与连接R3、R4之间的C形成五元或者六元环。
本发明中，所述R为Ns-、Ts-或Ms-；
R1为H、甲基、乙基、甲氧基、三氟甲基、F或Cl中的一个或者多个；
R2为H、甲基、苯基或Cl；
R3和R4独立地为甲基、异丙基或苯基；
或者R3和R4与连接R3、R4之间的C形成六元环。
本发明中，所述的钯催化剂为三氟乙酸钯。
本发明中，所述的助催化剂为醋酸铜。
本发明中，所述的有机溶剂为对二甲苯。
本发明中，以摩尔量计，所述的苯甲酰胺类化合物或丙烯酰胺类化合物：苯丙烯类化合物：钯催化剂：助催化剂＝1：1.5～2.5：0.1～0.2：0.2～0.3。
本发明中，反应温度为100～110℃，反应时间为12～24小时。
本发明中，所述的异喹啉酮类化合物为化合物3a～3q；
所述的吡啶酮类化合物为化合物5a～5i。
本发明中，所述的后处理包括柱层析。
同现有技术相比，本发明的技术效果如下：
本发明选择CONH-sulfonyl为导向基，以Pd(TFA)2为催化剂、催化量Cu(OAc)2和空气为共同氧化剂，实现苯甲酰胺和丙烯酰胺与苯丙烯经C-H烯丙基化/胺钯加成/β-H消除/异构化过程的串联反应，合成一系列异喹啉酮和吡啶酮化合物。该方法原料简单易得、条件温和、转化高效、区域选择性高、原子利用率高且操作简单，是非常具有应用价值的合成异喹啉酮和吡啶酮的方法。
具体实施方式
实施例1～13
10ml史莱克管中加入苯甲酰胺1a(0.2mmol)，苯丙烯2a(0.4mmol)，催化剂(0.02mmol)，助催化剂(0.04mmol)，对二甲苯2mL，加热反应24小时。然后将反应体系冷却至室温，砂芯过滤，乙酸乙酯洗涤，浓缩溶剂，用石油醚/乙酸乙酯＝5/1过柱得到目标产品3a，具体反应条件和反应结果见表1。
反应式如下：
Figure BDA0002972613120000031
表1实施例1～13的反应条件和反应结果
Figure BDA0002972613120000032
Figure BDA0002972613120000041
a反应条件:1a(0.2mmol),2a(0.4mmol),催化剂(0.02mmol),助催化剂(0.04mmol),对二甲苯(2ml),110℃空气氛围下反应24h；b分离收率；c加氧气气球；d100℃.
实施例14～29
10ml史莱克管中加入苯甲酰胺1(0.2mmol)，苯丙烯2(0.4mmol)，三氟乙酸钯(6.6mg,0.02mmol)，醋酸铜(7.3mg,0.04mmol)，对二甲苯2mL，110度敞口搅拌反应24小时。然后将反应体系冷却至室温，砂芯过滤，乙酸乙酯洗涤，浓缩溶剂，用石油醚/乙酸乙酯＝5/1或3/1过柱得到目标产品3b～3q，反应条件和结果如下：
Figure BDA0002972613120000042
实施例30～38
10ml史莱克管中加入丙烯酰胺4(0.2mmol)，苯丙烯2(0.4mmol)，三氟乙酸钯(6.6mg,0.02mmol)，醋酸铜(7.3mg,0.04mmol)，对二甲苯2mL，110度敞口搅拌反应24小时。然后将反应体系冷却至室温，砂芯过滤，乙酸乙酯洗涤，浓缩溶剂，用石油醚/乙酸乙酯＝5/1或3/1过柱得到目标产品5a～5i。
Figure BDA0002972613120000051
产物表征数据表征如下：
异喹啉酮：
3-Benzyl-2-((4-nitrophenyl)sulfonyl)isoquinolin-1(2H)-one(3a).Lightyellow solid；73.9mg；88％yield；Rf＝0.44(hexane/EtOAc＝5/1as the eluent)；mp＝193–194℃；1H NMR(400MHz,CDCl3)δ8.42–8.36(m,4H),7.97(dd,J＝7.8,1.4Hz,1H),7.48(td,J＝7.5,1.4Hz,1H),7.45–7.40(m,2H),7.37–7.32(m,4H),7.16(d,J＝7.6Hz,1H),6.82(s,1H),4.01(s,2H)；13C{1H}NMR(100MHz,CDCl3)δ163.1,150.6,145.3,137.9,134.3,134.1,130.4,130.3,130.0,129.0,128.7,128.1,128.0,127.7,127.2,126.8,124.1,32.1；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C22H16N2O5SNa)443.0678,found443.0676.
3-Benzyl-6-methyl-2-((4-nitrophenyl)sulfonyl)isoquinolin-1(2H)-one(3b).Light yellow solid；73.8mg；85％yield；Rf＝0.44(hexane/EtOAc＝5/1as theeluent)；mp＝208–209℃；1H NMR(400MHz,CDCl3)δ8.45–8.33(m,4H),7.85(d,J＝8.0Hz,1H),7.42(t,J＝7.4Hz,2H),7.36–7.32(m,3H),7.13(d,J＝8.1Hz,1H),6.96(s,1H),6.80(s,1H),3.96(s,2H),2.34(s,3H)；13C{1H}NMR(100MHz,CDCl3)δ163.2,150.5,145.6,145.4,137.9,134.1,130.7,130.3,129.4,129.0,128.7,128.6,128.0,127.8,127.7,124.2,124.1,32.0,21.7；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C23H18N2O5SNa)457.0834,found457.0837.
3-Benzyl-7-methyl-2-((4-nitrophenyl)sulfonyl)isoquinolin-1(2H)-one(3c).Light yellow solid；44.3mg；51％yield；Rf＝0.46(hexane/EtOAc＝5/1astheeluent)；mp＝172–173℃；1H NMR(400MHz,CDCl3)δ8.41–8.35(m,4H),7.76(s,1H),7.42(t,J＝7.4Hz,2H),7.37–7.32(m,3H),7.29(d,J＝8.1Hz,1H),7.05(d,J＝7.8Hz,1H),6.81(s,1H),3.96(s,2H),2.32(s,3H)；13C{1H}NMR(100MHz,CDCl3)δ163.3,150.5,145.3,137.7,135.2,135.0,134.1,130.6,130.3,129.5,129.0,128.7,128.0,127.8,127.1,126.5,124.1,31.7,21.0；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C23H18N2O5SNa)457.0834,found457.0839.
3-Benzyl-8-methyl-2-((4-nitrophenyl)sulfonyl)isoquinolin-1(2H)-one(3d).Light yellow solid；83.3mg；96％yield；Rf＝0.48(hexane/EtOAc＝5/1astheeluent)；mp＝189–190℃；1H NMR(400MHz,CDCl3)δ8.40–8.33(m,4H),7.41(t,J＝7.3Hz,2H),7.35–7.29(m,4H),7.12(d,J＝7.6Hz,1H),6.98(d,J＝7.4Hz,1H),6.83(s,1H),3.92(s,2H),2.58(s,3H)；13C{1H}NMR(100MHz,CDCl3)δ163.5,150.5,145.6,143.0,138.7,134.3,133.1,131.4,130.22,130.20,129.0,128.7,128.0,127.9,125.4,124.9,124.1,33.2,22.1；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C23H18N2O5SNa)457.0834,found457.0832.
3-Benzyl-6,8-dimethyl-2-((4-nitrophenyl)sulfonyl)isoquinolin-1(2H)-one(3e).Light yellow solid；85.1mg；95％yield；Rf＝0.49(hexane/EtOAc＝5/1astheeluent)；mp＝175–176℃；1H NMR(400 MHz,CDCl3)δ8.39–8.32(m,4H),7.41(t,J＝7.4Hz,2H),7.36–7.31(m,3H),6.93(s,1H),6.81(s,1H),6.79(s,1H),3.89(s,2H),2.53(s,3H),2.27(s,3H)；13C{1H}NMR(100MHz,CDCl3)δ163.5,150.4,145.7,144.1,143.0,138.8,134.4,132.2,130.4,130.1,129.0,128.7,127.9,127.7,125.6,124.0,122.6,33.1,22.0,21.4；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C24H20N2O5SNa)471.0991,found471.0985.
3-Benzyl-6-ethyl-2-((4-nitrophenyl)sulfonyl)isoquinolin-1(2H)-one(3f).Light yellow solid；83.3mg；93％yield；Rf＝0.45(hexane/EtOAc＝5/1astheeluent)；mp＝176–177℃；1H NMR(400MHz,CDCl3)δ8.41–8.35(m,4H),7.87(d,J＝8.1Hz,1H),7.43(t,J＝7.4Hz,2H),7.37–7.32(m,3H),7.15(d,J＝8.1Hz,1H),6.97(s,1H),6.80(s,1H),3.98(s,2H),2.63(q,J＝7.6Hz,2H),1.19(t,J＝7.6Hz,3H)；13C{1H}NMR(100MHz,CDCl3)δ163.1,151.7,150.5,145.4,138.0,134.2,130.6,130.3,129.5,129.1,128.7,128.0,127.8,127.5,126.6,124.3,124.1,32.1,29.0,15.0；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C24H20N2O5SNa)471.0991,found471.0986.
3-Benzyl-6-methoxy-2-((4-nitrophenyl)sulfonyl)isoquinolin-1(2H)-one(3g).Light yellow solid；74.7mg；83％yield；Rf＝0.47(hexane/EtOAc＝3/1as theeluent)；mp＝190–191℃；1H NMR(400MHz,CDCl3)δ8.40–8.35(m,4H),7.90(d,J＝8.8Hz,1H),7.42(t,J＝7.4Hz,2H),7.36–7.32(m,3H),6.88–6.74(m,2H),6.61(s,1H),3.97(s,2H),3.80(s,3H)；13C{1H}NMR(100MHz,CDCl3)δ164.3,162.8,150.5,145.6,140.3,134.2,131.7,130.6,130.2,129.0,128.7,128.0,127.7,124.1,119.3,113.8,111.8,55.6,32.4；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C23H18N2O6SNa)473.0783,found473.0774.
3-Benzyl-6-chloro-2-((4-nitrophenyl)sulfonyl)isoquinolin-1(2H)-one(3h).Light yellow solid；67.2mg；74％yield；Rf＝0.45(hexane/EtOAc＝5/1as theeluent)；mp＝216–217℃；1H NMR(400MHz,CDCl3)δ8.43–8.35(m,4H),7.90(d,J＝8.4Hz,1H),7.43(t,J＝7.4Hz,2H),7.37(d,J＝7.1Hz,1H),7.34–7.28(m,3H),7.17(s,1H),6.83(s,1H),3.97(s,2H)；13C{1H}NMR(100MHz,CDCl3)δ162.3,150.6,145.1,140.8,139.6,133.8,130.9,130.4,129.7,129.0,128.8,128.5,128.3,128.2,127.3,125.3,124.1,31.9；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C22H15ClN2O5SNa)477.0288,found477.0281.
3-Benzyl-6-fluoro-2-((4-nitrophenyl)sulfonyl)isoquinolin-1(2H)-one(3i).Light yellow solid；65.7mg；75％yield；Rf＝0.42(hexane/EtOAc＝5/1as theeluent)；mp＝193–194℃；1H NMR(400MHz,CDCl3)δ8.44–8.33(m,4H),7.99(dd,J＝8.8,5.6Hz,1H),7.43(t,J＝7.3Hz,2H),7.36(t,J＝7.5Hz,1H),7.32(d,J＝7.4Hz,2H),7.02(td,J＝8.5,2.5Hz,1H),6.86(dd,J＝8.5,2.4Hz,1H),6.83(s,1H),3.99(s,2H)；19F NMR(376MHz,CDCl3)δ-102.05–-102.11(m,1F)；13C{1H}NMR(100MHz,CDCl3)δ166.0(C–F,1JC–F＝258.0Hz),162.2,150.6,145.2,141.0(C–F,3JC–F＝9.2Hz),133.8,132.4(C–F,3JC–F＝10.2Hz),130.3,129.8,129.0,128.9,128.4,128.3,124.1,123.2(C–F,4JC–F＝2.8Hz),115.4(C–F,2JC–F＝22.3Hz),114.2(C–F,2JC–F＝22.6Hz),32.1；HRMS(ESI-TOF)m/z calcdfor[M+Na]+(C22H15FN2O5SNa)461.0583,found461.0582.
3-Benzyl-2-((4-nitrophenyl)sulfonyl)-6-(trifluoromethyl)isoquinolin-1(2H)-one(3j).Light yellow solid；47.8mg；49％yield；Rf＝0.48(hexane/EtOAc＝5/1asthe eluent)；mp＝174–175℃；1H NMR(400MHz,CDCl3)δ8.45–8.36(m,4H),8.10(d,J＝8.2Hz,1H),7.59(d,J＝8.2Hz,1H),7.47–7.43(m,3H),7.37(t,J＝7.2Hz,1H),7.33(d,J＝7.3Hz,2H),6.87(s,1H),4.07(s,2H)；19F NMR(376MHz,CDCl3)δ-63.34(s,3F)；13C{1H}NMR(100MHz,CDCl3)δ161.9,150.7,144.9,138.7,135.5(C–F,2JC–F＝33.0Hz),133.7,130.4,130.1,129.9,129.3,129.0,128.9,128.9,128.4,124.6(C–F,3JC–F＝3.6Hz),124.3(C–F,3JC–F＝3.7Hz),124.2,123.1(C–F,1JC–F＝271.7Hz),31.9；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C23H15F3N2O5SNa)511.0551,found511.0548.
3-Benzyl-2-tosylisoquinolin-1(2H)-one(3k).Light yellow solid；56.0mg；72％yield；Rf＝0.56(hexane/EtOAc＝5/1as the eluent)；mp＝179–180℃；1H NMR(400MHz,CDCl3)δ8.07(d,J＝8.4Hz,2H),8.00(d,J＝7.8Hz,1H),7.46–7.38(m,3H),7.36–7.29(m,6H),7.13(d,J＝7.6Hz,1H),6.84(s,1H),3.96(s,2H),2.43(s,3H)；13C{1H}NMR(100MHz,CDCl3)δ161.9,143.8,136.9,135.7,133.5,132.7,123.0,128.5,128.2,128.0,127.9,127.5,126.7,126.4,126.3,125.9,31.0,20.6；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C23H19NO3SNa)412.0983,found412.0981.
3-Benzyl-2-(methylsulfonyl)isoquinolin-1(2H)-one(3l).White solid；57.6mg；92％yield；Rf＝0.48(hexane/EtOAc＝3/1as the eluent)；mp＝159–160℃；1H NMR(400MHz,CDCl3)δ8.13(d,J＝7.8Hz,1H),7.51(t,J＝7.6Hz,1H),7.44–7.35(m,3H),7.34–7.26(m,3H),7.17(d,J＝7.7 Hz,1H),6.67(s,1H),3.97(s,2H),3.63(s,3H)；13C{1H}NMR(100MHz,CDCl3)δ164.3,138.2,134.3,134.1,130.5,129.4,129.0,128.6,127.8,127.6,127.2,126.8,44.1,32.1；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C17H15NO3SNa)336.0670,found336.0674.
3-(4-Methylbenzyl)-2-((4-nitrophenyl)sulfonyl)isoquinolin-1(2H)-one(3m).Light yellow solid；53.8mg；62％yield；Rf＝0.44(hexane/EtOAc＝5/1as theeluent)；mp＝201–202℃；1H NMR(400MHz,CDCl3)δ8.43–8.34(m,4H),7.96(dd,J＝7.9,1.4Hz,1H),7.48(td,J＝7.5,1.5Hz,1H),7.33(t,J＝7.2Hz,1H),7.25–7.20(m,4H),7.15(d,J＝7.5Hz,1H),6.78(s,1H),4.01(s,2H),2.39(s,3H)；13C{1H}NMR(100MHz,CDCl3)δ163.2,150.5,145.4,138.1,134.3,131.1,130.3,129.8,129.4,129.4,129.0,128.1,127.7,127.2,126.9,124.1,32.1,21.3；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C23H18N2O5SNa)457.0834,found457.0829.
3-(4-Chlorobenzyl)-2-((4-nitrophenyl)sulfonyl)isoquinolin-1(2H)-one(3n).Light yellow solid；48.1mg；53％yield；Rf＝0.45(hexane/EtOAc＝5/1as theeluent)；mp＝205–206℃；1H NMR(400MHz,CDCl3)δ8.44–8.34(m,4H),7.96(d,J＝7.8Hz,1H),7.50(t,J＝7.1Hz,1H),7.40(d,J＝8.3Hz,2H),7.35(t,J＝7.6Hz,1H),7.27(d,J＝6.9Hz,2H),7.16(d,J＝7.7Hz,1H),6.77(s,1H),3.97(s,2H)；13C{1H}NMR(100MHz,CDCl3)δ163.0,150.6,145.1,137.6,134.5,134.1,132.5,130.9,130.4,130.3,129.4,129.0,127.9,127.2,126.74,126.71,124.1,32.0；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C22H15ClN2O5SNa)477.0288,found477.0288.
吡啶酮：
3-Benzyl-2-((4-nitrophenyl)sulfonyl)-5,6,7,8-tetrahydroisoquinolin-1(2H)-one(5a).Light yellow solid；44.9mg；53％yield；Rf＝0.43(hexane/EtOAc＝5/1asthe eluent)；mp＝177–178℃；1H NMR(400MHz,CDCl3)δ8.39(d,J＝8.3Hz,2H),8.32(d,J＝8.6Hz,2H),7.40(t,J＝7.5Hz,2H),7.34–7.28(m,3H),6.66(s,1H),3.34(s,2H),2.23–2.07(m,4H),1.65–1.58(m,4H)；13C{1H}NMR(100MHz,CDCl3)δ163.8,151.2,150.4,145.8,134.1,130.1,129.8,129.1,128.6,127.9,126.4,126.0,124.1,34.0,30.4,22.7,21.6,21.5；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C22H20N2O5SNa)447.0991,found447.0999.
6-Benzyl-3,4-dimethyl-1-((4-nitrophenyl)sulfonyl)pyridin-2(1H)-one(5b).Light yellow solid；35.8mg；45％yield；Rf＝0.46(hexane/EtOAc＝5/1as theeluent)；mp＝190–191℃；1H NMR(400MHz,CDCl3)δ8.39(d,J＝9.0Hz,2H),8.31(d,J＝8.9Hz,2H),7.41(t,J＝7.3Hz,2H),7.33(t,J＝7.3Hz,1H),7.29(d,J＝7.0Hz,2H),6.68(s,1H),3.41(s,2H),1.86(s,3H),1.75(s,3H)；13C{1H}NMR(100MHz,CDCl3)δ164.0,150.4,149.1,145.7,134.0,130.1,129.5,129.1,128.6,127.9,126.4,124.4,124.0,35.2,20.3,11.8；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C20H18N2O5SNa)421.0834,found421.0838.
6-Benzyl-3-methyl-1-((4-nitrophenyl)sulfonyl)-4-phenylpyridin-2(1H)-one(5c).Yellow solid；40.5mg；44％yield；Rf＝0.46(hexane/EtOAc＝5/1as theeluent)；mp＝166–167℃；1H NMR(400MHz,CDCl3)δ8.44–8.37(m,4H),7.41–7.29(m,8H),7.11–7.06(m,2H),6.76(s,1H),3.72(s,2H),1.77(s,3H)；13C{1H}NMR(100MHz,CDCl3)δ164.6,150.5,150.3,145.6,138.0,133.9,130.2,129.6,129.0,128.9,128.7,128.7,129.0,127.4,126.8,125.7,124.1,35.3,13.6；HRMS(ESI-TOF)m/z calcd for[M+Na]+(C25H20N2O5SNa)483.0991,found483.0991。

Claims (8)

1.一种合成异喹啉酮类化合物或吡啶酮类化合物的方法，其特征在于，包括：在钯催化剂和助催化剂的作用下，苯甲酰胺类化合物(1)或丙烯酰胺类化合物(4)与苯丙烯类化合物(2)在有机溶剂中进行反应，反应结束后经过后处理得到所述的异喹啉酮类化合物(3)或吡啶酮类化合物(5)；
反应式如下：
Figure FDA0002972613110000011
或
Figure FDA0002972613110000012
上式中，R为苯基或者烷基取代的磺酰基；
R1为H、C1～C4烷基、C1～C4烷氧基、三氟甲基或卤素中的一个或者多个；
R2为H、C1～C4烷基、苯基或卤素；
R3和R4为苯基、C1～C4烷基，或者R3、R4与连接R3、R4之间的C形成五元或者六元环。
2.根据权利要求1所述的合成异喹啉酮类化合物或吡啶酮类化合物的方法，其特征在于，所述R为Ns-、Ts-或Ms-；
R1为H、甲基、乙基、甲氧基、三氟甲基、F或Cl中的一个或者多个；
R2为H、甲基、苯基或Cl；
R3和R4独立地为甲基、异丙基或苯基；
或者R3和R4与连接R3、R4之间的C形成六元环。
3.根据权利要求1所述的合成异喹啉酮类化合物或吡啶酮类化合物的方法，其特征在于，所述的钯催化剂为三氟乙酸钯。
4.根据权利要求1所述的合成异喹啉酮类化合物或吡啶酮类化合物的方法，其特征在于，所述的助催化剂为醋酸铜。
5.根据权利要求1所述的合成异喹啉酮类化合物或吡啶酮类化合物的方法，其特征在于，所述的有机溶剂为对二甲苯。
6.根据权利要求1所述的合成异喹啉酮类化合物或吡啶酮类化合物的方法，其特征在于，以摩尔量计，所述的苯甲酰胺类化合物或丙烯酰胺类化合物：苯丙烯类化合物：钯催化剂：助催化剂＝1：1.5～2.5：0.1～0.2：0.2～0.3。
7.根据权利要求1所述的合成异喹啉酮类化合物或吡啶酮类化合物的方法，其特征在于，反应温度为100～110℃，反应时间为12～24小时。
8.根据权利要求1所述的合成异喹啉酮类化合物或吡啶酮类化合物的方法，其特征在于，所述的异喹啉酮类化合物为化合物3a～3q；
所述的吡啶酮类化合物为化合物5a～5i。
CN202110267724.2A 2021-03-12 2021-03-12 一种合成异喹啉酮类化合物或吡啶酮类化合物的方法 Active CN113149895B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110267724.2A CN113149895B (zh) 2021-03-12 2021-03-12 一种合成异喹啉酮类化合物或吡啶酮类化合物的方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110267724.2A CN113149895B (zh) 2021-03-12 2021-03-12 一种合成异喹啉酮类化合物或吡啶酮类化合物的方法

Publications (2)

Publication Number Publication Date
CN113149895A true CN113149895A (zh) 2021-07-23
CN113149895B CN113149895B (zh) 2022-07-05

Family

ID=76886862

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110267724.2A Active CN113149895B (zh) 2021-03-12 2021-03-12 一种合成异喹啉酮类化合物或吡啶酮类化合物的方法

Country Status (1)

Country Link
CN (1) CN113149895B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115260096A (zh) * 2022-08-19 2022-11-01 武汉大学 一种基于一氧化碳气体或一氧化碳替代源合成二氢异喹啉酮类化合物的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110204491A (zh) * 2019-06-18 2019-09-06 台州学院 一种手性3,4-二氢异喹啉酮化合物的合成方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110204491A (zh) * 2019-06-18 2019-09-06 台州学院 一种手性3,4-二氢异喹啉酮化合物的合成方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JING-WEN XUE ET AL.: "Palladium(II)/Lewis Acid-Catalyzed Oxidative Olefination/Annulation of N-Methoxybenzamides: Identifying the Active Intermediates through NMR Characterizations", 《THE JOURNAL OF ORGANIC CHEMISTRY》, vol. 84, 26 June 2020 (2020-06-26), pages 8760 - 8772 *
MANMAN SUN ET AL.: "Palladium-Catalyzed Tandem Dehydrogenative [4 + 2] Annulation of Terminal Olefins with N‑Sulfonyl Amides via C−H Activations", 《ORGANIC LETTERS》, vol. 22, 27 March 2020 (2020-03-27), pages 3229 - 3233 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115260096A (zh) * 2022-08-19 2022-11-01 武汉大学 一种基于一氧化碳气体或一氧化碳替代源合成二氢异喹啉酮类化合物的方法
CN115260096B (zh) * 2022-08-19 2024-04-09 武汉大学 一种基于一氧化碳气体或一氧化碳替代源合成二氢异喹啉酮类化合物的方法

Also Published As

Publication number Publication date
CN113149895B (zh) 2022-07-05

Similar Documents

Publication Publication Date Title
CN113045489B (zh) 一种3-芳基喹啉-2(1h)酮衍生物的制备方法
CN112321593B (zh) 一种吲哚并[1,2-a]喹唑啉-6(5H)-酮化合物的制备方法
CN107868036B (zh) 一种多取代苯并[c,d]吲哚类化合物的合成方法
CN107141246B (zh) 一种靛红衍生物的制备方法
CN113149895B (zh) 一种合成异喹啉酮类化合物或吡啶酮类化合物的方法
Samzadeh-Kermani Ethynylation of isoquinoline and quinoline derivatives with calcium carbide
CN114195711B (zh) 一种喹啉-4(1h)-酮化合物的制备方法
CN107935925B (zh) 一种多取代菲啶化合物的制备方法
CN115772157B (zh) 一种2-烷氧基吲哚化合物的制备方法
CN105017043B (zh) α‑烷基支链取代的α‑氨基酸衍生物的合成方法
CN108912076B (zh) 一种苯并氧杂环化合物的合成方法
CN115260080B (zh) 一种吲哚-3-甲酰胺化合物的制备方法
Harayama et al. Aryl–Aryl Coupling Reaction Using a Novel and Highly Active Palladium Reagent Prepared from Pd (OAc) 2, 1, 3-Bis [diphenylphosphino] propane (DPPP), and Bu3P
CN113698358B (zh) 一种可见光诱导合成喹唑啉酮化合物的方法
CN109912663A (zh) 氧链接环戊二烯铑络合物、其制备方法、中间体及应用
CN113444041B (zh) 一种光催化合成多取代喹啉类化合物的方法
CN111004164B (zh) 一种多取代2-芳基吲哚衍生物的制备方法
CN110862347B (zh) 一种2-芳基取代喹啉氮氧化合物的制备方法
CN107619386A (zh) 一种芳环并[c]咔唑类衍生物及其合成方法
CN110357879B (zh) 一种c-3苄基吲嗪类化合物的制备方法
CN108484602B (zh) 一种多取代氮杂三环嗪衍生物的制备方法
CN103242223A (zh) 一种2-吡啶氧基二芳基甲酮衍生物的制备方法
CN112239456B (zh) 一种取代2，3-二氢喹诺酮化合物的制备方法
CN108816290A (zh) 一种Ullmann C-N交叉偶联反应催化剂及基于其的合成方法
CN114057694B (zh) 一种7-马来酰亚胺吲哚类化合物的制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant